This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tallent, S. M.
Right arrow Articles by Edmond, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tallent, S. M.
Right arrow Articles by Edmond, M. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2002, p. 2249-2250, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2249-2250.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Vancomycin Susceptibility of Oxacillin-Resistant Staphylococcus aureus Isolates Causing Nosocomial Bloodstream Infections

Sandra M. Tallent,1* Tammy Bischoff,1 Michael Climo,1,2 Belinda Ostrowsky,1 Richard P. Wenzel,1 and Michael B. Edmond1

Department of Internal Medicine, Medical College of Virginia Campus of Virginia Commonwealth University,1 Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia2

Received 19 December 2001/ Returned for modification 29 January 2002/ Accepted 1 March 2002

Nosocomial oxacillin-resistant Staphylococcus aureus (ORSA) bloodstream isolates were tested to determine the prevalence of vancomycin heteroresistance. We screened 619 ORSA nosocomial bloodstream isolates from 36 hospitals between 1997 and 2000. Only one isolate exhibiting heterotypic resistance was detected. Thus, vancomycin heteroresistance in clinical bloodstream isolates remains rare in the United States.

* Corresponding author. Mailing address: Virginia Commonwealth University, P.O. Box 980019, Richmond, VA 23298. Phone: (804) 827-0725. Fax: (804) 828-3602. E-mail: smtallen{at}hsc.vcu.edu.

Journal of Clinical Microbiology, June 2002, p. 2249-2250, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2249-2250.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chua, T., Moore, C. L., Perri, M. B., Donabedian, S. M., Masch, W., Vager, D., Davis, S. L., Lulek, K., Zimnicki, B., Zervos, M. J. (2008). Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Urban Detroit. J. Clin. Microbiol. 46: 2345-2352 [Abstract] [Full Text]  
  • Kim, H. B., Park, W. B., Lee, K. D., Choi, Y. J., Park, S. W., Oh, M.-d., Kim, E.-C., Choe, K. W. (2003). Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea. J. Clin. Microbiol. 41: 2279-2281 [Abstract] [Full Text]  
  • Mutnick, A. H, Kirby, J. T, Jones, R. N (2003). CANCER Resistance Surveillance Program: Initial Results from Hematology-Oncology Centers in North America. The Annals of Pharmacotherapy 37: 47-56 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»